A novel approach to attenuate proliferative vitreoretinopathy using ultrasound‐targeted microbubble destruction and recombinant adeno‐associated virus‐mediated RNA interference targeting transforming growth factor‐β2 and platelet‐derived growth factor‐B
A novel approach to attenuate proliferative vitreoretinopathy using ultrasound‐targeted microbubble destruction and recombinant adeno‐associated virus‐mediated RNA interference targeting transforming growth factor‐β2 and platelet‐derived growth factor‐B
Your
PayPal account has been charged $4.99. You now have access to the full text of this article. A rental receipt has also been sent to your email address.
Your
credit card
has been charged $4.99. You now have access to the full text of this article. A rental receipt has also been sent to your email address.
We've noted your interest in this PDF and will work with our publisher partner to discuss enabling downloads for this journal.
In the meantime, you can read the full article by renting it.
Thank you for purchasing with DeepDyve
Your PayPal account has been charged $.
Your credit card has been charged $.
You can now download this article. A receipt has also been sent to your email.
Thank you for purchasing with DeepDyve
Your PayPal account has been charged
.
Your credit card has been charged .
You will receive an email confirming your purchase and a second email with instructions on downloading the PDF.
Order status:
Download Article
To download this article, please log in first, or sign up for a DeepDyve account if you don't already have one.
Printing Pages Not Available for this Article
Thanks for your interest in printing individual pages. Your request has been noted and we will work with our publisher partner to discuss enabling this feature.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don't already have one.